Clinical Trials
38 trialsAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Canadian Cancer Trials Group
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Cancer Trials Ireland
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Danish Gynecological Cancer Group
Abemaciclib and Letrozole to Treat Endometrial Cancer
GOG Foundation
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Canadian Cancer Trials Group
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Canadian Cancer Trials Group
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Radiation Therapy Oncology Group
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
Radiation Therapy Oncology Group
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
Canadian Cancer Trials Group
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Canadian Cancer Trials Group
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Radiation Therapy Oncology Group
Lenvatinib in Second Line Endometrial Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
GOG Foundation
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
GOG Foundation
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
GOG Foundation
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
GOG Foundation
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
GOG Foundation
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
GOG Foundation
Chemotherapy in Treating Patients With Sarcoma of the Uterus
GOG Foundation
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
GOG Foundation
Quality of Life in Survivors of Gynecologic Cancer
GOG Foundation
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
GOG Foundation
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
GOG Foundation
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
GOG Foundation
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
GOG Foundation
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
European Organisation for Research and Treatment of Cancer - EORTC
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
SWOG Cancer Research Network